Manava Plus and the Interreg Italy–Switzerland project Xeno is developing human brain organoids to study neurodegenerative diseases like Parkinson's.

Manava Plus is pioneering revolutionary spinal cord and brain injury treatments, aiming to turn permanent disability into a temporary challenge. Our mission is to develop neural prostheses that restore disrupted circuits caused by spinal cord injury, allowing patients to walk and feel again We are working to realise Neural Control Interface technology integrating autologous spinal organoids on a microchip with AI control; aiming at personalized patients care that would empower people with neurological impairments to gain a new life.